Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng-Ju Wu

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Nature Cancer|March 14, 2023
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancersLei Shi, William Shen, Mindy I Davis, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targetsVindhya Vijay, Negin Karisani, Lei Shi, et al.
Science (New York, N.Y.)|July 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunityMeng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, et al.
Cancer Discovery|May 12, 2025
Generation of a biliary tract cancer cell line atlas identifies molecular subtypes and therapeutic targetsVindhya Vijay, Negin Karisani, Lei Shi, et al.
Nature|October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Nature Cancer|March 14, 2023
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancersLei Shi, William Shen, Mindy I Davis, et al.
Biorxiv : the Preprint Server for Biology|July 19, 2024
Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targetsVindhya Vijay, Negin Karisani, Lei Shi, et al.
Science (New York, N.Y.)|July 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunityMeng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula, et al.
Cancer Discovery|May 12, 2025
Generation of a biliary tract cancer cell line atlas identifies molecular subtypes and therapeutic targetsVindhya Vijay, Negin Karisani, Lei Shi, et al.
Nature|October 4, 2023
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunityChristina K Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta-Vellve, et al.
Pageof 4